COVID-19 Information: Vaccine | Testing | Self-assessment | Patient & Visitor Safety | Visitor Policy
Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Details
Back to Results
Request Additional Trial InformationFull Trial Details: ClinicalTrials.gov
Condition: Non-Hodgkins LymphomaStudy Type: InterventionalPhase: IIIStudy Start Date: 02/10/2017Study Completion Date: 07/2022
This is a randomized study to assess the efficacy and safety of the study drug ublituximab and TGR-1202 with or without Bendamustine and then TGR-1202 alone in patients with previously treated Non-Hodgkin’s Lymphoma.
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.